Invests in
Stages:
Locations:
Min Investment:
$15,000,000.00Max Investment:
$30,000,000.00Target Investment:
$22,500,000.00
Skills
Education
Lists including Vincent
Investments
Work Experience
2007
Executive Director
2022
Partner
2007 - 2022
Representing Abingworth, have served on the Boards of Chiasma, Dicerna Pharmaceuticals, Dynex Technologies, Hydra Biosciences, IFM Therapeutics, IFM Due, IFM Tre, IFM Quattro, Magellan Diagnostics, Personalis and PrimeraDx, and as a Board observer at Atsena Therapeutics and Nido Biosciences. Abingworth is a life-sciences venture capital firm that invests mainly in companies discovering and developing novel therapeutics for unmet clinical needs.
2003 - 2007
Senior VP, Business Development
2003 - 2007
1997 - 2003
VP, Business Development, Technology Management
1997 - 2003
1996 - 1997
Director, Office of Technology Transfer
1996 - 1997
1992 - 1996
VP, R&D and Business Development
1992 - 1996
1986 - 1992
VP, International Marketing (Molecular Biology Division)
1989 - 1992
VP, R&D (Molecular Biology Division)
1986 - 1990
1978 - 1986
R&D and Business Development
1978 - 1986
1975 - 1978
Higher Scientific Officer
1975 - 1978